History of present illness
According to patient he was alright
until 7 years back then he noticed a
swelling on proximal arm, initially it
was small in size, gradually it increased
in size and became huge within 4
months.
There is no hx of trauma, fever, weight
loss and pain.
Systemic Inquiries
GPE, CVS, CNS, Respiratory, GIT & Urinary systems
are normal.
Systemic symptoms such as fever, weight loss, and
night sweat are absent.
Past medical & Surgical History
He has operated three times for same mass.
He has received 3 dose of chemotherapy and radiation in 2017.
Family History
•Married
•5 sons & 2 daughter
General Physical & Systemic
Examination
No anemia, pallor and weight loss.
Focused Examination
LOOK
Round shaped mass on anterolateral aspect of right
proximal arm , skin over the swelling is lost and
necrosed .
Margins of mass is red and there is no dilated vein
around .
Previous surgical scar is present.
No visible muscle wasting of arm, forearm & wrist.
Focused Examination…..
FEEL
Local skin temperature is warm as compared to normal
side.
Tenderness –ve
Distal pulses normal.
Sensations intact
Soft tissue sarcoma
Introduction
Soft tissue sarcomas are malignant tumor that
originate in soft tissues of body.
Common sites.
Extremity 43 %
Visceral 19 %
Retroperitoneal 15 %
Trunk or thoracic 10 %
Others 13 %
Etiologies
Radiation exposure.
Chronic lymphedema.
Trauma.
Chemical exposure e.g. arsenic, polyvinyl chloride.
Infections such as herpes human virus.
Imaging
MRI
For extremity mass.
Give good delineation between muscles, tumor and
blood vessels.
Pet scan
May help to determine high vs low grade
May be helpful in recurrence.
Metastatic workup
Evaluation for site of potential metastasis
Lymph nodes metastasis occur in less than 3 %
For extremity lesion lung is the principle site for
metastasis.
Staging
AJCC/UICC staging system for soft tissue sarcomas
T1: <5 cm
T1a: Superficial to muscular fascia
T1b: Deep to muscular fascia
T2: >5 cm
T2a: Superficial to muscular fascia
T2b: Deep to muscular fascia
N1: Regional lymph node involvement
Adjuvant radiotherapy
Small low grade tumor <5 cm resected with 2 cm
margin may not require radiation
Adjuvant radiotherapy should be added to surgical
resection .
1. if excission margin is close
2. if extra muscular involvement is present
3. if local recurrence would result in sacrifice of major
neurovascular bundle or amputation.
It improves local recurrence but not survival
Radiotherapy
Can be given as brachytheraphy or intraoperative
radiotherapy
Brachytheraphy for high grade lesion
External beam radiation therapy for large >5cm high or
low grade leission
Intraoperative radiotherapy can be given in case of
retroperitoneal sarcoma
Can be given as preoperative and post operative
Chemotherapy
Can improve local control but not survival
Doxorubicin and Ifosfamide have response rate of 20%
Used only in advance disease
Combination with radiation or neoadjuvant therapy
are controversial
Metastatic disease
Lung is most common site of mets.
Median survival after metastatic disease is 8 to 12
months
Resection of pulmonary mets can give 5 year survival
of 32 % if all mets can be removed
>3 mets poor prognosis